FMR LLC 13D and 13G filings for Day One Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-04-07 1:22 pm Sale | 2026-03-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 23,640 0.000% | -5,693,368 (-99.59%) | Filing |
| 2026-02-05 1:20 pm Sale | 2025-12-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 5,717,008 5.600% | -4,380,660 (-43.38%) | Filing |
| 2025-11-05 11:30 am Sale | 2025-09-30 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 10,097,668 9.900% | -1,245,031 (-10.98%) | Filing |
| 2025-08-06 11:56 am Sale | 2025-06-30 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 11,342,699 11.200% | -1,544,768 (-11.99%) | Filing |
| 2025-02-12 09:28 am Purchase | 2024-12-31 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 12,887,467 12.800% | 1,600,140 (+14.18%) | Filing |
| 2024-11-07 09:24 am Purchase | 2024-11-06 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 11,287,327 11.192% | 3,874,947 (+52.28%) | Filing |
| 2024-11-07 09:12 am Purchase | 2024-11-06 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 7,412,380 7.539% | 3,444,214 (+86.80%) | Filing |
| 2024-02-09 08:50 am Sale | 2024-02-08 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 3,968,166 4.558% | -2,050,892 (-34.07%) | Filing |
| 2023-08-10 08:19 am Sale | 2023-08-09 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 6,019,058 6.931% | -2,983,252 (-33.14%) | Filing |
| 2023-02-09 09:59 am Purchase | 2023-02-09 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 9,002,310 12.239% | 693,136 (+8.34%) | Filing |
| 2022-09-12 11:13 am Purchase | 2022-09-09 | 13G | DAY ONE BIOPHARMACEUTICALS INC DAWN | FMR LLC | 8,309,174 11.310% | 8,309,174 (New Position) | Filing |